As of 2026-09-17, the Relative Valuation of Jazz Pharmaceuticals PLC (JAZZ) is 256.08 USD. This relative valuation is based on P/E multiples. With the latest stock price at 243.59 USD, the upside of Jazz Pharmaceuticals PLC based on Relative Valuation is 5.1%.
The range of the Relative Valuation is 215.65 - 326.17 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 21.8x | 15.6x |
| Forward P/E multiples | 14.8x - 20.8x | 18.6x |
| Fair Price | 215.65 - 326.17 | 256.08 |
| Upside | -11.5% - 33.9% | 5.1% |
| Date | P/E |
| 2026-09-16 | 16.27 |
| 2026-09-15 | 16.08 |
| 2026-09-14 | 16.42 |
| 2026-09-11 | 16.41 |
| 2026-09-10 | 16.06 |
| 2026-09-09 | 16.11 |
| 2026-09-08 | 16.03 |
| 2026-09-04 | 16.48 |
| 2026-09-03 | 16.53 |
| 2026-09-02 | 16.40 |
| 2026-09-01 | 16.27 |
| 2026-08-31 | 16.74 |
| 2026-08-28 | 16.33 |
| 2026-08-27 | 16.77 |
| 2026-08-26 | 16.65 |
| 2026-08-25 | 17.38 |
| 2026-08-24 | 16.99 |
| 2026-08-21 | 16.98 |
| 2026-08-20 | 16.61 |
| 2026-08-19 | 16.84 |
| 2026-08-18 | 16.90 |
| 2026-08-17 | 16.58 |
| 2026-08-14 | 16.36 |
| 2026-08-13 | 16.42 |
| 2026-08-12 | 16.62 |
| 2026-08-11 | 16.56 |
| 2026-08-10 | 17.13 |
| 2026-08-07 | 17.13 |
| 2026-08-06 | 17.14 |
| 2026-08-05 | 17.47 |
| 2026-08-04 | 17.47 |
| 2026-08-03 | 16.80 |
| 2026-07-31 | 16.88 |
| 2026-07-30 | 17.25 |
| 2026-07-29 | 17.09 |
| 2026-07-28 | 17.16 |
| 2026-07-27 | 17.06 |
| 2026-07-24 | 16.95 |
| 2026-07-23 | 17.02 |
| 2026-07-22 | 16.72 |
| 2026-07-21 | 16.98 |
| 2026-07-20 | 16.26 |
| 2026-07-17 | 16.53 |
| 2026-07-16 | 16.17 |
| 2026-07-15 | 15.98 |
| 2026-07-14 | 15.90 |
| 2026-07-13 | 15.82 |
| 2026-07-10 | 16.28 |
| 2026-07-09 | 16.49 |
| 2026-07-08 | 16.58 |